EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FAK and Pyk2: Paralogous Kinases with Opposing Roles in Vasculogenic Mimicry in Triple-Negative Breast Cancer

Shilpa Madhavan-Kadali iD, Tal Sneh, Naamah Bloch iD, Joseph D Rosenblatt, Abraham O Samson, Hava Gil-Henn

International Journal of Molecular Sciences · 06.07.2026 · 27 (13) · 6053

DOI: 10.3390/ijms27136053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.07.2026. Verfasst von Shilpa Madhavan-Kadali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Focal Adhesion Kinase 2, Neovascularization, Pathologic, Focal Adhesion Kinase 1. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Cancer Association, Israel Cancer Research Fund, Israel Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vasculogenic mimicry (VM) is a non-endothelial mode of tumor vascularization in which aggressive cancer cells form vessel-like networks that support microcirculation, metastasis, and resistance to anti-angiogenic therapies. VM is particularly prominent in triple-negative breast cancer (TNBC), but its molecular regulators remain incompletely understood. Focal adhesion kinase (FAK) and its paralog, proline-rich tyrosine kinase 2 (Pyk2), are closely related non-receptor tyrosine kinases implicated in epithelial-to-mesenchymal transition (EMT), invasion, and metastasis in TNBC. However, their roles in VM have not been defined. Here we perform transcriptomic analysis of FAK and Pyk2 clinical expression patterns using TNMplot V2, DepMap, and patient cohort datasets to systematically dissect the distinct contributions of FAK and Pyk2 to VM in TNBC. Our in vitro tube formation assay shows that in TNBC cells, knockdown of FAK, but not Pyk2, results in failure to form robust 3D vessel-like networks in Matrigel. Similarly, overexpression of Pyk2, but not FAK, in TNBC cells results in poor vessel-like network formation. Consistent with these findings, analysis of two independent patient cohorts (TCGA-BRCA and METABRIC) revealed selective upregulation of FAK in TNBC, while Pyk2 was inversely associated with vasculogenic-mimicry-associated gene expression, supporting the opposing roles of the two kinases in patient tumors. Taken together, these findings establish that FAK and Pyk2 govern VM through non-redundant, kinase-specific, and functionally opposed mechanisms: FAK acting as a positive regulator of VM, and Pyk2 as a context dependent suppressor of VM at elevated levels. These results nominate FAK as a candidate target for suppressing VM-driven tumor perfusion in TNBC and suggest that dual FAK/Pyk2 inhibition warrants caution hypotheses that remain to be tested pharmacologically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsFocal Adhesion Kinase 2Neovascularization, PathologicFocal Adhesion Kinase 1HumansFemaleMDA-MB-231 CellsHEK293 CellsAnimalsMiceHeterograftsCell Movement

Stichwörter der Autor:innen

FAKPTK2PTK2BPyk2cell migrationfocal adhesion kinasenon-receptor tyrosine kinasestriple negative breast cancertumor vascularizationvasculogenic mimicry

Substanzen

Focal Adhesion Kinase 2PTK2B protein, humanFocal Adhesion Kinase 1

Autor:innen und Institutionen

  • Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel.
  • Department of Medicine, Division of Hematology, Sylvester Comprehensive Cancer Centre, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Integrated Imaging Program for Cancer Research, Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

ORCID-Profile: Shilpa Madhavan-Kadali, Naamah Bloch

Förderung

  • Israel Cancer Association
  • Israel Cancer Research Fund
  • Israel Science Foundation
  • Florida Department of Health
  • Katz Foundation
  • Department of Defense
  • Florida Department of Health Bankhead Coley Cancer Research Program

Zitieren

APA

Madhavan-Kadali, S., Sneh, T., Bloch, N., Rosenblatt, J. D., Samson, A. O., & Gil-Henn, H. (2026). FAK and Pyk2: Paralogous Kinases with Opposing Roles in Vasculogenic Mimicry in Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 27(13), 6053. https://doi.org/10.3390/ijms27136053

Vancouver

Madhavan-Kadali S, Sneh T, Bloch N, Rosenblatt JD, Samson AO, Gil-Henn H. FAK and Pyk2: Paralogous Kinases with Opposing Roles in Vasculogenic Mimicry in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2026;27(13):6053. doi:10.3390/ijms27136053

BibTeX
@article{MadhavanKadali2026,
  author = {Madhavan-Kadali, Shilpa and Sneh, Tal and Bloch, Naamah and Rosenblatt, Joseph D and Samson, Abraham O and Gil-Henn, Hava},
  title = {FAK and Pyk2: Paralogous Kinases with Opposing Roles in Vasculogenic Mimicry in Triple-Negative Breast Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {6053},
  doi = {10.3390/ijms27136053}
}
Kostenlos starten →